Latest Articles

04. 01. 2018

A New System of DCP Slots Allocation with SÚKL as the RMS

SÚKL informs about a new system of slots allocation within the scope of decentralised procedures (DCP) with SÚKL as the Reference Member State (RMS), effective as of 1...

 

29. 12. 2017

List of reimbursed medicinal products valid as of 1.1.2018

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

14. 12. 2017

Amendments to protocol and updates to clinical trial dossier following the issuance of authorisation/approval of the conduct of the clinical trial

Clinical trial sponsors are kindly requested to send amendments to the protocol and updates to an approved/authorised clinical trial dossier in electronic format only.

 

08. 12. 2017

GDPR – General Data Protection Regulation and clinical trials

Communication notifying clinical trial sponsors that SÚKL will not assess or approve consents with ensuring personal data protection

 

30. 11. 2017

List of reimbursed medicinal products valid as of 1.12.2017

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

02. 11. 2017

Correction of the List of reimbursed medicinal products valid as of 2.11.2017

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

31. 10. 2017

List of reimbursed medicinal products valid as of 1.11.2017

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...